Jennifer N. Saultz - Concepedia

Author

Jennifer N. Saultz

Oregon Health & Science University ORCID

Also Known As

Dr. Jennifer N Saultz, J Saultz, J. Saultz, Jennifer Saultz, Jennifer N Saultz, Jennifer N. Saultz, Jennifer Saultz

151

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Oregon Health & Science University The Ohio State University City Of Hope National Medical Center City of Hope Stanford University

About

Jennifer N. Saultz is an author at Oregon Health & Science University specializing in medicine, cancer research, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	201
2	Cell Biology	2	2	96
3	Public Health	1	1	84
4	Cellular Therapies	1	1	17
5	Epidemiology	1	1	84

Jennifer N. Saultz

Publications

927

Citations

H-Index

Page 1

	Year	Citations
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia Daniel Bottomly, Nicola Long, Anna Reister Schultz, Cancer Cell	2022	336
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia Adam J. Lamble, Yoko Kosaka, Ted Laderas, Proceedings of the National Academy of Sciences	2020	97
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia Curtis A. Lachowiez, Nicola Long, Jennifer N. Saultz, Blood Advances Mixed-phenotype Acute LeukemiaPathologyLogistic AnalysisMyeloid NeoplasiaHematological Malignancy	2022	84
SMAD4 promotes TGF-β–independent NK cell homeostasis and maturation and antitumor immunity Youwei Wang, Jianhong Chu, Ping Yi, Journal of Clinical Investigation	2018	81
Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function Steven D. Scoville, Ansel P. Nalin, Luxi Chen, Blood	2018	80
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia Jihane Khalife, Hanna S. Radomska, Ramasamy Santhanam, Leukemia Hematological MalignancyMixed-phenotype Acute LeukemiaMicrorna DetectionSmall RnaRadiation Oncology	2015	79
Integrative Analysis of Drug Response and Clinical Outcome in Acute Myeloid Leukemia Daniel Bottomly, Nicola Long, Anna Reister Schultz, SSRN Electronic Journal	2022	31
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML Curtis A. Lachowiez, Vishvaas I Ravikumar, Jad Othman, Blood	2024	24
The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704 Andrew Artz, Brent R. Logan, Wael Saber, Blood	2023	21
Headache prevalence following recovery from TTP and aHUS Jennifer N. Saultz, Haifeng Wu, Spero R. Cataland Annals of Hematology Cluster HeadacheHeadache PrevalenceIntracranial PressureBrain InjuryNeurology	2015	21

Page 1